Septerna (SEPN) Common Equity (2023 - 2026)
Septerna's (SEPN) quarterly Common Equity came in at $378.5 million in Q1 2026, up 194.55% year-on-year from $128.5 million in Q1 2025, and down 0.91% quarter-over-quarter from $381.9 million in Q4 2025.
Septerna (SEPN) Common Equity (2023 - 2026) Analysis & Trends
Septerna's Common Equity history runs 4 years deep, the most recent figure standing at $378.5 million for Q1 2026.
- On a quarterly basis, Common Equity rose 194.55% year-over-year to $378.5 million in Q1 2026; TTM through Mar 2026 was $378.5 million, a 194.55% increase from a year earlier, with the FY2025 full-year figure at $381.9 million, down 9.08% from the prior year.
- Common Equity eased to $378.5 million in Q1 2026 per SEPN's latest filing, from $381.9 million in the prior quarter.
- Across five years, Common Equity topped out at $420.0 million in Q4 2024 and bottomed at -$400.3 million in Q1 2025.
- The 4-year median for Common Equity is -$38.4 million (2023), against an average of $111.6 million.
- Across the five-year window, Common Equity surged 1194.61% in 2024 and slumped 671.31% in 2025, its largest moves.
- Year by year, Common Equity stood at -$38.4 million in 2023, then jumped by 1194.61% to $420.0 million in 2024, then declined by 9.08% to $381.9 million in 2025, then retreated by 0.91% to $378.5 million in 2026.
- Per Business Quant, the three latest SEPN Common Equity figures stand at $378.5 million (Q1 2026), $381.9 million (Q4 2025), and $388.7 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 251.12 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | -98.34 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 4.76 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 32.36 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 19.36 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 31.42 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 795.79 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 1.50 Bn |
| 10 | Septerna | 1.50 Bn | 1.50 Bn | - | 378.46 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 378.46 Mn |
| Dec 31, 2025 | 381.93 Mn |
| Sep 30, 2025 | 388.73 Mn |
| Jun 30, 2025 | 377.56 Mn |
| Mar 31, 2025 | -400.27 Mn |
| Dec 31, 2024 | 420.05 Mn |
| Sep 30, 2024 | -87.41 Mn |
| Jun 30, 2024 | -67.76 Mn |
| Mar 31, 2024 | -51.89 Mn |
| Dec 31, 2023 | -38.37 Mn |
| Sep 30, 2023 | -73.85 Mn |